Clinical Pharmacokinetics

, Volume 46, Issue 9, pp 805–805 | Cite as

The Authors′ Reply

  • Matthias Schwab
Correspondence
  • 12 Downloads

Keywords

Inflammatory Bowel Disease Renal Transplantation Breast Milk Rheumatic Disease Therapeutic Response 

References

  1. 1.
    Teml A, Schaeffeler E, Herrlinger KR, et al. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet 2007; 46: 187–208PubMedCrossRefGoogle Scholar
  2. 2.
    Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504–17PubMedCrossRefGoogle Scholar
  3. 3.
    Mahadevan U, Kane S. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131: 278–82PubMedCrossRefGoogle Scholar
  4. 4.
    Mahadevan U, Kane S. American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131: 283–311PubMedCrossRefGoogle Scholar
  5. 5.
    EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV. 10. pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002; 17 Suppl. 4: 50–5Google Scholar
  6. 6.
    Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005; 35: 112–21PubMedCrossRefGoogle Scholar
  7. 7.
    Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 2006; 55: 1198–206PubMedCrossRefGoogle Scholar
  8. 8.
    Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 7th ed. Philadelphia (PA): Lippincott, Williams & Wilkins, 2005Google Scholar
  9. 9.
    Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705–13PubMedCrossRefGoogle Scholar
  10. 10.
    Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord 2003; 3 Suppl. 1: S30–8PubMedGoogle Scholar
  11. 11.
    Kaskas BA, Louis E, Hindorf U, et al. Safe treatment of thiopurine S-methyltransferase deficient Crohn’s disease patients with azathioprine. Gut 2003; 52: 140–2PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Authors and Affiliations

  • Matthias Schwab
    • 1
    • 2
  1. 1.Dr Margarete Fischer-Bosch Institute of Clinical PharmacologyStuttgart, and University of TübingenTübingenGermany
  2. 2.Department of Clinical PharmacologyUniversity HospitalTübingenGermany

Personalised recommendations